comparemela.com

Latest Breaking News On - Durect - Page 1 : comparemela.com

DURECT Co. (NASDAQ:DRRX) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of DURECT Co. (NASDAQ:DRRX – Get Free Report) have received a consensus rating of “Moderate Buy” from the five research firms that are presently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12-month target […]

Investors-inc
Cm-management
Ironwood-investment-management
Richmond-brothers-inc
Nasdaq
Company-profile
Get-free-report
Investment-management
Accredited-investors
Get-free
Durect

DURECT Co. (NASDAQ:DRRX) Short Interest Down 10.0% in April

DURECT Co. (NASDAQ:DRRX – Get Free Report) was the recipient of a large decline in short interest in April. As of April 15th, there was short interest totalling 927,500 shares, a decline of 10.0% from the March 31st total of 1,030,000 shares. Based on an average daily volume of 169,000 shares, the short-interest ratio is […]

Silverberg-bernstein-capital-management
Durect-co
Ironwood-investment-management
Cm-management
Richmond-brothers-inc
Nasdaq
Get-free-report
Bernstein-capital-management
Investment-management
Durect
Nasdaq-drrx

Brokerages Set DURECT Co. (NASDAQ:DRRX) Price Target at $27.50

Shares of DURECT Co. (NASDAQ:DRRX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the five brokerages that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price objective […]

Richmond-brothers-inc
Walleye-capital
Vanguard-group-inc
Silverberg-bernstein-capital-management
Nasdaq
Virtu-financial
Get-free-report
Bernstein-capital-management
Get-free
Durect
Nasdaq-drrx

DURECT Co. (NASDAQ:DRRX) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of DURECT Co. (NASDAQ:DRRX – Get Free Report) have received an average recommendation of “Moderate Buy” from the five analysts that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12-month target […]

Millennium-management
Armistice-capital
Vanguard-group-inc
Nasdaq
Renaissance-technologies
Get-free-report
Street-corp
Get-free
Durect
Nasdaq-drrx
Drrx

DURECT (NASDAQ:DRRX) Cut to Sell at StockNews.com

StockNews.com lowered shares of DURECT (NASDAQ:DRRX – Free Report) from a hold rating to a sell rating in a report released on Friday morning. Other equities research analysts have also issued research reports about the company. HC Wainwright lowered DURECT from a buy rating to a neutral rating in a research report on Tuesday, November […]

Investors-inc
Cm-management
Diamond-financial
Gagnon-securities
Free-report
Accredited-investors
Get-free-report
Durect
Nasdaq-drrx
Drrx
Medical

vimarsana © 2020. All Rights Reserved.